Company
Seres Therapeutics
Our mission is to transform the lives of patients worldwide with revolutionary live biotherapeutics.
Also known as Seres Therapeutics, Inc.
- Status
- Operatingas of 2026-09-18
- Business model
- B2B
- Legal name
- Seres Therapeutics, Inc.
Claim, correct or request removal
Record updated 28 September 2026
About
Seres Therapeutics is a clinical stage biotechnology company developing new therapies comprised of rationally selected live bacteria consortia.
Funding snapshot
- Total raised
- $124MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $65M2014-12-19
Funding rounds
- Round, 2014
- $65M2014-12-19, SEC form D sold, 1 investor
- Round, 2014
- $48M2014-11-24, SEC form D sold, 20 investors
- Round, 2014
- $10.6M2014-05-23, SEC form D sold, 10 investors
Products
- Other
- VOWST
Loading relationship preview